Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TERT | O14746 | 7/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HPGDS | O60760 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240601 | 0.81 | MAP4K4 (0.51) | SMN1; SMN2KDRLMNA | |
| SCHEMBL31240564 | 0.80 | DYRK1A (0.48) | ALDH1A1TERTKDRHPGDSACHE | |
| SCHEMBL31240682 | 0.75 | CDC7 (0.42) | — | |
| SCHEMBL15444518 | 0.74 | ALDH1A1 (0.97) | ALDH1A1TERTSMN1; SMN2POLBLMNA | |
| SCHEMBL31240646 | 0.70 | CHUK (0.62) | ALDH1A1SMN1; SMN2LMNAKMT2A | |
| SCHEMBL31240729 | 0.70 | CD74 (0.50) | — | |
| SCHEMBL4667937 | 0.70 | AURKA (0.51) | ALDH1A1TERTSMN1; SMN2POLBHPGDS | |
| SCHEMBL14005995 | 0.69 | CHRNA7 (0.80) | — | |
| SCHEMBL14005977 | 0.69 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2POLB | |
| SCHEMBL19294806 | 0.69 | L3MBTL1 (0.79) | ALDH1A1SMN1; SMN2POLBLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |